Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | EDNRB | P24530 | 1/20 | 0.32 |
| ▸ | EDNRA | P25101 | 1/20 | 0.32 |
| ▸ | CDK8 | P49336 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20152313 | 0.96 | EDNRB (0.33) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL20152316 | 0.91 | KDM4E (0.34) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL22958711 | 0.88 | KDM4E (0.40) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL22958775 | 0.88 | KDM4E (0.42) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL22958735 | 0.80 | EDNRB (0.37) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL22958791 | 0.79 | KDM4E (0.37) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL19035949 | 0.79 | KDM4E (0.41) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL22958719 | 0.79 | L3MBTL1 (0.39) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL20152314 | 0.78 | PTPRC (0.34) | KDM4EATML3MBTL1CDK8 | |
| SCHEMBL6123827 | 0.78 | KDM4E (0.52) | KDM4EATML3MBTL1EDNRBEDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10844059-B2 | Heterocyclic compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-11-24 | — | — | US | disclosed |
| US-20180134706-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
| US-20180134706-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134706-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | OR10J3, HDAC10, RBM12 | KDM4E 565/4885ATM 3724/4885L3MBTL1 2661/4885 |
| US-10844059-B2 | Heterocyclic compound and organic electroluminescence device including the same | OR10J3, HDAC10, RBM12 | KDM4E 565/4885ATM 3724/4885L3MBTL1 2661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.